Crown Prince and Vertex Pharmaceuticals CEO Discuss Medical Milestone and Future Collaborations
According to Bahrain News Agency, His Royal Highness highlighted Bahrain's recent medical milestone wherein the Kingdom successfully treated the world's first sickle cell disease patient outside the United States using Casgevy (exagamglogene autotemcel). This CRISPR-based gene-editing therapy was accomplished through advanced bone marrow transplantation technology.
His Royal Highness reaffirmed the importance of strengthening Bahrain's partnership with Vertex Pharmaceuticals, aiming to explore future opportunities that will bolster the Kingdom's health sector. This partnership is expected to enhance Bahrain's position as a leader in scientific and medical advancements.
Prince Salman emphasized Bahrain's commitment to collaborating with leading international specialized medical institutions, ensuring the Kingdom remains at the forefront of scientific progress. He stressed the importance of integrating cutting-edge treatments into the healthcare and rehabilitation services available to Bahrainis, underscoring this as a top priority for the Kingdom's health initiatives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Tribune
17-07-2025
- Daily Tribune
Bahrain's Health Sector Celebrates Major Achievements and International Recognition
Bahrain's Minister of Health, Dr. Jalila bint Al-Sayed Jawad Hassan, highlighted the remarkable achievements made by Bahrainis across various sectors, especially in healthcare. She emphasized that these successes reflect a strong, ongoing commitment to development that strengthens the kingdom's position and supports its comprehensive progress under the leadership of His Majesty King Hamad bin Isa Al Khalifa and His Royal Highness Crown Prince Salman bin Hamad Al Khalifa. Dr. Jalila praised the dedicated efforts of healthcare and administrative teams, whose work has played a vital role in raising the quality of services for both citizens and residents. The minister made these remarks during a meeting attended by Dr. Asad Hafeez, Acting WHO Representative in Bahrain, along with public health officials and teams that recently received local and international awards for leading healthcare projects. Among the honored were the National Genome Project team and the Organ Donation Platform team, recognized locally, as well as the National Influenza Center and the National Measles and Rubella Elimination Program, which received international awards. Dr. Jalila expressed great pride in these accomplishments, noting they are the result of ongoing guidance from the Supreme Council of Health and strong partnerships with international organizations, especially the World Health Organization. Recently, the Ministry of Health won two awards at the Bahrain Digital Content Awards 2025 for the Organ Donation Platform "Min Man Ahyaha" and the registration of participants in the National Genome Project under the 'Health and Wellness' category. These initiatives were praised for their positive impact on improving health prevention and providing advanced digital health services. The minister also commended the National Influenza Center at the Public Health Laboratories for receiving its 12th consecutive World Health Organization external quality assessment certification in influenza and COVID-19 virus detection, showcasing Bahrain's high laboratory standards. Additionally, she praised the National Program to Eliminate Measles and Rubella for renewing its international certification from the WHO, confirming the kingdom's ongoing success in eradicating these diseases through effective vaccination programs and advanced epidemiological surveillance. During the meeting, Dr. Jalila stressed the importance of building on these achievements by continuing to embrace innovation, digital transformation, and the development of national talents to ensure the sustainability of Bahrain's healthcare excellence. The honored teams expressed their gratitude to the minister and health officials for their support, pledging to maintain a united effort to serve the community's health and achieve even greater national and international successes.
Daily Tribune
14-07-2025
- Daily Tribune
Push Brings Care : MP-backed plan now activated
TDT | Manama Access to emergency care for sickle cell anaemia patients in Bahrain has entered a new phase, with the Government Hospitals Administration launching 24-hour operations at the Hereditary Blood Disorders Centre (HBDC) in Salmaniya Medical Complex. The move follows a strong parliamentary call earlier this year to provide faster and more specialised care for patients facing unpredictable pain crises. On January 22nd, Parliament approved a proposal by Dr Maryam Al Dhaen to create a separate emergency pathway with dedicated staff for sickle cell cases. Care on Call Dr Maryam Athbi Al Jalahma, CEO of Government Hospitals, said the round-the-clock service will improve emergency response times, cut down on waiting periods, and ensure high-quality, efficient care that meets patient needs. 'This reflects our commitment to providing integrated, sustainable healthcare,' she said. HBDC has been the central point for treating hereditary blood disorders, yet patients have long struggled with delays during off-hours. The expansion to 24/7 care directly addresses these gaps. Parliamentary Push During the parliamentary session in January, Dr Al Dhaen emphasised that sickle cell patients face sudden, severe attacks that require immediate medical response. 'Sickle cell patients can be struck by intense attacks at any moment. The sooner they get the right care, the better their chances,' she said. She anchored her proposal in Article 8 of Bahrain's Constitution, which affirms the right of every citizen to healthcare. The plan also calls for more accurate genetic testing, better screening measures, and expanded use of preimplantation genetic testing (PGT) to prevent future cases. Support and Impact Zakaria Ibrahim Al Kazem, Chairman of the Bahrain Sickle Cell Society, welcomed the announcement and described it as a 'significant advance in healthcare standards.' He said the move demonstrated continued support for those affected by hereditary conditions. With sickle cell anaemia among the most common inherited disorders in the Kingdom, the updated care model is expected to reduce pressure on emergency services and improve patient outcomes. Part of Bigger Shift Earlier this year, Bahrain made headlines as the first country in the region to administer Casgevy, a gene therapy for sickle cell treatment that uses CRISPR technology. Alongside the launch of 24-hour care, the development reflects a growing emphasis on both innovation and access. Authorities say both preventive and medical strategies are needed to protect public health and manage long-term costs. Bahrain's sickle cell community may now have a stronger system to depend on, whether day or night.
Gulf Insider
12-07-2025
- Gulf Insider
Bahrain Announces Online Registration For Hajj 2026
The Supreme Committee for Hajj and Umrah in Bahrain has announced that all registrations for the 2026 Hajj season (1447 AH) will be carried out exclusively online through the official website. The committee emphasized that only individuals who meet the required health conditions will be accepted. This includes being physically fit and free from chronic or contagious illnesses, as per health guidelines issued by the Kingdom of Saudi Arabia. To register, applicants must have a passport valid for at least six months beyond their travel date. Access to the registration platform requires either an electronic key (eKey) or a one-time password (OTP). However, this verification step does not apply to citizens of GCC countries. Priority Groups for Hajj Special priority will be given to: * Bahrainis who have never performed Hajj * Bahraini women who have never performed Hajj and are accompanied by a Bahraini male who has previously performed Hajj * Non-Bahraini wives of Bahraini citizens * Bahraini men over the age of 60 who have not previously performed Hajj * Persons with disabilities, accompanied by someone who has performed Hajj before Next Steps After Approval Those who are initially accepted will be notified within seven days to complete their registration. They must: * Choose a campaign and package * Confirm their participation by paying BD 150 per person * Sign the unified contract electronically This fee will be considered part of the total package cost, and the application will be confirmed upon payment. Refund and Privacy PolicyThe committee has strictly prohibited campaign operators from sharing registrant data. In cases of emergency cancellations — such as death or illness that prevents travel — refunds may be issued based on the timing of the cancellation, following the approved policy. Medical Criteria for Eligibility To ensure the safety of pilgrims, applicants must not suffer from: * Organ failure (heart, lungs, liver, kidneys) * Severe neurological or psychological conditions that impair cognition or mobility * Dementia-related conditions * Advanced pregnancy (last two months) or high-risk pregnancy at any stage * Active cancer under treatment (chemotherapy, radiotherapy, or immunotherapy) * Infectious diseases impacting public health, such as open tuberculosis or hemorrhagic fevers The move to digital-only registration aims to streamline the process and ensure health and safety standards are met for all intending pilgrims.
